Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1998
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009618A2 Graft survival prolongation with porphyrins
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009526A1 Antioxidant derived from lentil and its preparation and uses
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998DE19636150A1 N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung N-substituted indole-3-glyoxylamides with anti-asthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264924A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264654A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2259969A1 Phospholipase d and dna sequences
03/12/1998CA2234886A1 Graft survival prolongation with porphyrins
03/11/1998EP0827964A2 S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleo-side complexes as potent inhibitors of HIV-replication
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827507A1 Protease inhibiting succinic acid derivatives
03/11/1998EP0827408A1 Method of administration of igf-i
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0710279A4 Yolk sac stem cells and their uses
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/11/1998CN1175463A Anti-senility hypolipemic Chinese medicine liquor
03/11/1998CN1037682C Process for preparing 2 -hydroxymethyl -5 -(5 -fluorocytosin -1 -yl) -1 ,3 -oxathiolane
03/10/1998US5726312 Methods for preparing antiproliferative 5-substituted pyrimidone compounds
03/10/1998US5726305 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5725878 Pharmaceutical composition comprising HIV protease inhibiting compounds
03/10/1998US5725864 Contacting susceptible lymphoid cells with antiviral amount of iron-binding protein or derivative thereof
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008545A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998WO1998008536A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008509A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998CA2599944A1 P-selectin ligand proteins
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263935A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263133A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies
03/04/1998EP0826673A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826303A1 A method of preventing animals from diseases and improving immune function of animals
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826006A1 Transeptithelial transport of molecular species
03/04/1998EP0826001A1 Acellular pertussis vaccines and methods of preparation thereof
03/04/1998EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
03/04/1998EP0825993A1 Xanthines and their therapeutic use
03/04/1998EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
03/04/1998EP0825983A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0825874A1 Composition of tyrosine and polymerised allergen
03/04/1998EP0700293B1 Dihydrotestosterone for use in androgenotherapy
03/04/1998EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/04/1998CN1175264A Novel cyclodextrin-derivatives and method for the preparation thereof
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1175209A 3, 3 -(disubstituted) cyclohexan -1 -ols monomers and related compounds
03/04/1998CN1174707A Lucid ganoderma oral liquid and preparation process
03/03/1998US5723681 3,3-(disubstituted)cyclohexan-1-01 dimers and related compounds
03/03/1998US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
03/03/1998US5723465 Inhibitors for cell adhesion and cellular infiltration
03/03/1998US5723463 Pyrido 3,2-E!pyrazinones with anti-asthmatic action and processes for their manufacture
03/03/1998US5723460 Potent and selective phosphodiesterase type iv inhibitors; useful in the prophylaxis and treatment of disease such as asthma where unwanted inflammatory response or muscular spasm is present
1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 1172